SPH4336 not checked

Shanghai Pharmaceuticals Holding Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
4 active
6 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“SPH4336 Tablets :Orally, 400mg once a day; 28 days/cycle Letrozole tablets :Orally, 2.5mg once a day; 28 days/cycle”In the company’s words, NCT05744687 on ClinicalTrials.gov
Tested for
Locally Advanced or Metastatic Breast Cancer (2 trials), Breast Cancer Brain Metastases, Advanced Solid Tumors
Main trialPhase 2/3
“This study is designed to evaluate the safety and efficacy of SPH4336 combined with letrozole in first-line treatment of locally advanced or metastatic breast cancer”In the company’s words, NCT05744687 on ClinicalTrials.gov

Other drugs for Locally Advanced or Metastatic Breast Cancer

All 396 drugs for Locally Advanced or Metastatic Breast Cancer

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting 31 May 2026 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Phase 2/3Recruiting 1 Dec 2026 Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Phase 2Recruiting 31 Dec 2026 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Phase 1/2Recruiting 31 Dec 2026 A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Phase 2Terminated 4 Oct 2024 Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
Phase 1/2Completed 26 Oct 2023 Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SPH4336

Following is part of Solo: you see every change to SPH4336 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in